Seeds Investor LLC Invests $214,000 in Relx Plc $RELX

Seeds Investor LLC bought a new stake in Relx Plc (NYSE:RELX) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 3,934 shares of the technology company’s stock, valued at approximately $214,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in RELX. Goldman Sachs Group Inc. lifted its holdings in Relx by 4.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 4,072,342 shares of the technology company’s stock worth $205,287,000 after buying an additional 173,976 shares in the last quarter. Ameriprise Financial Inc. increased its position in shares of Relx by 8.3% during the first quarter. Ameriprise Financial Inc. now owns 3,041,132 shares of the technology company’s stock worth $154,129,000 after acquiring an additional 234,094 shares during the last quarter. Northern Trust Corp lifted its stake in shares of Relx by 9.2% in the first quarter. Northern Trust Corp now owns 2,394,097 shares of the technology company’s stock worth $120,686,000 after acquiring an additional 202,509 shares in the last quarter. Natixis Advisors LLC boosted its holdings in Relx by 0.5% in the first quarter. Natixis Advisors LLC now owns 1,208,467 shares of the technology company’s stock valued at $60,919,000 after purchasing an additional 5,875 shares during the last quarter. Finally, JPMorgan Chase & Co. grew its stake in Relx by 1.1% during the 2nd quarter. JPMorgan Chase & Co. now owns 854,100 shares of the technology company’s stock valued at $46,412,000 after purchasing an additional 8,913 shares in the last quarter. Hedge funds and other institutional investors own 15.02% of the company’s stock.

Relx Price Performance

NYSE RELX opened at $40.63 on Friday. Relx Plc has a one year low of $39.31 and a one year high of $56.33. The company has a 50-day simple moving average of $44.85 and a 200-day simple moving average of $49.29. The company has a quick ratio of 0.42, a current ratio of 0.47 and a debt-to-equity ratio of 2.55.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on RELX shares. Wall Street Zen lowered Relx from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Weiss Ratings cut shares of Relx from a “buy (b-)” rating to a “hold (c+)” rating in a report on Wednesday. Morgan Stanley reiterated an “overweight” rating on shares of Relx in a research note on Thursday, September 11th. Kepler Capital Markets raised shares of Relx from a “hold” rating to a “strong-buy” rating in a research report on Thursday, September 18th. Finally, Barclays reaffirmed an “overweight” rating on shares of Relx in a research report on Tuesday, October 7th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Buy”.

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.